Powerful AF: GUNK Launches Acetone-Free Brake Cleaner Ahead of EPA's PCE Phase-Out

GUNK introduced an acetone-free brake parts cleaner, available now in 14 oz and 19 oz sizes, that the company says out-cleaned tested leading non-chlorinated cleaners by 70% in internal laboratory testing. The low-VOC formula is compliant in 49 states, excluding California, as the EPA is set to ban sales of consumer products containing PCE beginning in early 2027. The launch positions GUNK to serve demand for compliant alternatives, though the performance comparison is limited to tested products and results may vary.

Analysis

The investable signal is regulatory substitution, not the product launch itself. As PCE-based consumer brake cleaners exit, shelf space and professional-shop purchasing can migrate to compliant formulations; incumbents with validated alternatives and retailer distribution may defend share better than brands relying on legacy formulas. Solvent suppliers and aerosol formulators could see mix shift, but the launch provides no evidence of category growth or durable pricing power. GUNK is part of privately held B'laster Holdings, so the direct exposure is not a listed equity. CHD’s licensed OxiClean trademark is unrelated to this brake-cleaner launch; no meaningful CHD read-through is supported.

Near term, the key uncertainty is whether technicians adopt the formula based on independently reproducible performance, not the company’s internal comparison. Over 1–3 months, watch retailer placement, repeat orders, and competing reformulations. Over 6–18 months, enforcement and state-level VOC rules could accelerate compliant-product substitution, while competing brands may narrow any performance gap. The California exclusion also limits the product’s regulatory reach. A reversal would be delayed or softened enforcement, weak adoption, or evidence that compliant substitutes perform adequately at lower prices. No listed-equity trade is justified on this release alone.

Key Decisions for Investors

• No direct trade in CHD: the OxiClean trademark license does not establish economic exposure to GUNK’s brake-cleaner launch.
• Treat this as a watch item for privately held B'laster Holdings and competitors such as CRC Industries and Permatex; verify distribution, repeat-purchase evidence, and independent product testing before inferring share gains.
• Monitor EPA implementation and retailer assortment changes into early 2027. A broad, enforced phaseout plus sustained adoption would strengthen the compliant-formulation substitution thesis; delays or weak sell-through would invalidate it.
• Avoid extrapolating the reported 70% internal-test advantage into pricing power or market-share gains without the tested-product list, test methodology, and real-world technician feedback.